Cigna offers discounted Stelara biosimilar, building on Humira move

Ever­north, the health ser­vices arm of in­sur­ance be­he­moth Cigna, is plan­ning to make a Ste­lara biosim­i­lar avail­able for $0 out-of-pock­et for se­lect pa­tients.

The move …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.